Evonile Pharma Overview
- Year Founded
-
1947
- Status
-
Public
- Employees
-
59
- Stock Symbol
-
500672
- Investments
-
2
- Share Price
-
$16.17
- (As of Friday Closing)
Evonile Pharma General Information
Description
Evonile Pharma Ltd Formerly Novartis India Ltd is a healthcare-focused pharmaceutical company dedicated to delivering high-quality therapeutic solutions that addresses the evolving needs of patients and healthcare professionals. It is engaged in the business of trading of Pharmaceuticals. Its therapeutic areas include pain management & orthopedics, women's health, nutrition & wellness, neurosciences, transplantation & immunology, oncology & specialty care, and cardiovascular care. The company has a single operating segment namely Pharmaceutical Business, and generates revenues from its operations in India.
Contact Information
Website
www.evonilepharma.comCorporate Office
- Inspire BKC, 7th Floor, Bandra-Kurla Complex
- Bandra (East)
- Mumbai, Maharashtra 400051
- India
Corporate Office
- Inspire BKC, 7th Floor, Bandra-Kurla Complex
- Bandra (East)
- Mumbai, Maharashtra 400051
- India
Evonile Pharma Stock Performance
As of 13-Nov-2026, Evonile Pharma’s stock price is $16.17. Its current market cap is $474M with 29.3M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $16.17 | $16.90 | $6.89 - $22.90 | $474M | 29.3M | 11.7K | -$0.01 |
Evonile Pharma Financials Summary
As of 30-Sep-2026, Evonile Pharma has a trailing 12-month revenue of $36.3M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 426,421 | 188,087 | 157,150 | 245,532 |
| Revenue | 36,272 | 40,098 | 42,132 | 40,350 |
| EBITDA | 1,264 | 10,703 | 10,931 | 8,649 |
| Net Income | (430) | 10,545 | 11,933 | 10,290 |
| Total Assets | 237,130 | 103,682 | 110,804 | 110,912 |
| Total Debt | 82,874 | 340 | 592 | 836 |
Evonile Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Evonile Pharma Comparisons
Industry
Financing
Details
Evonile Pharma Competitors (19)
One of Evonile Pharma’s 19 competitors is Alkem Laboratories, a Formerly PE-Backed company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alkem Laboratories | Formerly PE-Backed | Mumbai, India | ||||
| Zydus Lifesciences | Corporation | Ahmedabad, India | ||||
| Dr. Reddy's | Corporation | Hyderabad, India | ||||
| GSK | Corporation | London, United Kingdom | ||||
| Johnson&Johnson Innovative Medicine | Venture Capital-Backed | Raritan, NJ |
Evonile Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Evonile Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Evonile Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Evonile Pharma Investments & Acquisitions (2)
Evonile Pharma’s most recent deal was a Merger/Acquisition with Business Standard. The deal was made on 08-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Business Standard | 08-Sep-2026 | Merger/Acquisition | Publishing | ||
| Pfizer (Minipress and Minipres Portfolio in India) | 07-Sep-2026 | Buyout/LBO | Buildings and Property |
Evonile Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Evonile Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Business Standard | New Delhi, India | 1975 |
Evonile Pharma FAQs
-
When was Evonile Pharma founded?
Evonile Pharma was founded in 1947.
-
Where is Evonile Pharma headquartered?
Evonile Pharma is headquartered in Mumbai, India.
-
What is the size of Evonile Pharma?
Evonile Pharma has 59 total employees.
-
What industry is Evonile Pharma in?
Evonile Pharma’s primary industry is Pharmaceuticals.
-
Is Evonile Pharma a private or public company?
Evonile Pharma is a Public company.
-
What is Evonile Pharma’s stock symbol?
The ticker symbol for Evonile Pharma is 500672.
-
What is the current stock price of Evonile Pharma?
As of 13-Nov-2026 the stock price of Evonile Pharma is $16.17.
-
What is the current market cap of Evonile Pharma?
The current market capitalization of Evonile Pharma is $474M.
-
What is Evonile Pharma’s current revenue?
The trailing twelve month revenue for Evonile Pharma is $36.3M.
-
Who are Evonile Pharma’s competitors?
Alkem Laboratories, Zydus Lifesciences, Dr. Reddy's, GSK, and Johnson&Johnson Innovative Medicine are some of the 19 competitors of Evonile Pharma.
-
What is Evonile Pharma’s annual earnings per share (EPS)?
Evonile Pharma’s EPS for 12 months was -$0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
